Malondialdehyde in benign prostate hypertrophy: a useful marker?

• Autors principals: Rosaria Alba Merendino (Autor), Francesco Salvo (Autor), Antonella Saija (Autor), Giuseppe Di Pasquale (Autor), Antonio Tomaino (Autor), Paola Lucia Minciullo (Autor), Giuseppe Fraccica (Autor), Sebastiano Gangemi (Autor)
• Format: Llibre
• Publicat: Hindawi Limited, 2003-01-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Benign prostate hypertrophy (BPH) is the most common benign tumor in men due to obstruction of the urethra and, finally, uremia. Malondialdehyde (MDA) is a product derived from peroxidation of polyunsaturated fatty acids and related esters. Evaluation of MDA in serum represents a non-invasive biomar...